The rise of Sildenafil initially drove a surge for pharma, nevertheless recent developments present a murky outlook for those considering a stake. Generic alternatives are eating into profits, and ongoing patent https://matheyrts739677.blogdomago.com/39706613/viagra-and-the-pharmaceutical-industry-a-precarious-investment